ArticleFrontiers in endocrinology2021

Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway.

Yu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.